Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 12.70
0.00 (0.00%)
Aug 26, 2026, 1:51 PM CST
Vectorite Biomedical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 118.22 | 96.17 | -40.05 | -6.6 | -26.41 | 8.36 |
Depreciation & Amortization | 7.19 | 8.14 | 8.76 | 9.16 | 8.86 | 16.49 |
Other Amortization | - | - | - | - | - | 0.02 |
Loss (Gain) From Sale of Assets | - | -0.04 | - | - | - | - |
Asset Writedown & Restructuring Costs | 5.37 | 5.63 | 15.77 | 0.73 | - | - |
Loss (Gain) From Sale of Investments | -143.48 | -119.04 | 6.4 | -3.88 | 0.98 | -51.05 |
Loss (Gain) on Equity Investments | - | - | - | - | - | 5.84 |
Provision & Write-off of Bad Debts | - | - | - | - | - | 0.02 |
Other Operating Activities | 2.2 | -0.03 | -0.02 | -0.03 | -0.04 | -0.02 |
Change in Accounts Receivable | 3.93 | 3.34 | -0.47 | -0.05 | -4.48 | 1.17 |
Change in Inventory | 0.24 | -0.18 | -4.75 | -5.21 | 2.41 | -1.92 |
Change in Accounts Payable | -0.32 | -0.22 | -0.06 | -1.98 | 0.47 | 1.06 |
Change in Unearned Revenue | 0.47 | -0.88 | 1.83 | -2.53 | -0.81 | 2.66 |
Change in Other Net Operating Assets | 1.41 | 1.34 | 1.1 | 5.62 | -6.42 | -2.82 |
Operating Cash Flow | -4.76 | -5.79 | -11.51 | 1.3 | 14.7 | -65.79 |
Operating Cash Flow Growth | - | - | - | -91.17% | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -4 | -4 | -2.84 | -4.76 | -0.89 | -1.8 |
Sale of Property, Plant & Equipment | 0.04 | 0.04 | - | - | - | - |
Sale (Purchase) of Real Estate | 0.35 | - | - | - | - | - |
Investment in Securities | 14.71 | 5.62 | 24.08 | 1.33 | -25.2 | -39.88 |
Other Investing Activities | 1.01 | -0.32 | -4.87 | -0.4 | -0.25 | 0.01 |
Investing Cash Flow | 12.11 | 1.35 | 16.36 | -3.82 | -26.34 | -41.67 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.14 | - | - | - | - |
Total Debt Repaid | -0.17 | -0.14 | - | - | - | - |
Net Debt Issued (Repaid) | -0.17 | -0.14 | - | - | - | - |
Issuance of Common Stock | - | - | - | - | - | 118.08 |
Other Financing Activities | - | -0.2 | 0.2 | - | - | - |
Financing Cash Flow | -0.17 | -0.34 | 0.2 | - | - | 118.08 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.3 | -0.11 | 0.23 | -0.04 | 0.32 | -0.18 |
Net Cash Flow | 7.48 | -4.89 | 5.29 | -2.56 | -11.32 | 10.44 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.76 | -9.78 | -14.35 | -3.46 | 13.81 | -67.59 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -15.98% | -15.93% | -24.84% | -6.19% | 32.19% | -234.93% |
Free Cash Flow Per Share | -0.20 | -0.22 | -0.33 | -0.08 | 0.32 | -1.57 |
Levered Free Cash Flow | -3.2 | -6.08 | -12.32 | -9.41 | -19.78 | -11.42 |
Unlevered Free Cash Flow | -3.2 | -6.07 | -12.32 | -9.41 | -19.78 | -11.42 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.01 | 0.01 | - | - | - | - |
Cash Income Tax Paid | - | - | - | - | - | -0.01 |
Change in Working Capital | 5.74 | 3.39 | -2.36 | 1.92 | 31.32 | -45.45 |